Hyperbaric oxygen therapy enables pain reduction... (2024 study) Skip to main content
Study Ann Dermatol Venereol 2024

Hyperbaric oxygen therapy enables pain reduction and healing in painful chronic wounds, including in calciphylaxis

Pathault E, Sanchez S, Husson B, Vanhaecke C, Georges P, Brazier C, et al., Ann Dermatol Venereol, 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

French researchers reviewed the records of 18 patients treated from 2008 to 2021 who had chronic painful wounds that were not diabetic foot ulcers, and who had received hyperbaric oxygen therapy (HBOT) sessions, to see how their pain medicine use changed.

What They Found

In this retrospective study of 18 patients with chronic painful wounds, strong opioid use was lower after HBOT than before it (72.2 percent before versus 11.1 percent after, p = 0.005). A decrease in pain medicine step, dose or number was noted in 15 of 18 patients (83.3 percent), within a median of 3.5 months. Local improvement of the wound was also noted in 15 of 18 patients (83.3 percent), within a median of 3.9 months. The patients had calciphylaxis (6), vasculitis (4), hypertensive leg ulcer (3), mixed ulcer (3), Buerger's disease (1) and livedoid vasculitis (1). Analgesic use was followed for up to 12 months after HBOT.

What This Means for Canadian Patients

This was a single-center review of past records with no comparison group, so it cannot show that HBOT caused the drop in opioid use or the wound improvement. The authors describe HBOT as an add-on treatment in these painful wounds and say the finding needs to be shown in prospective, controlled studies. Patients with a painful chronic wound should talk with their own doctor about their options.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study was retrospective, took place at one center, included only 18 patients with several different wound causes, and had no control group, so the authors call for prospective, controlled studies to confirm the findings.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Wound Care
Source Pubmed
PubMed ID 39579606
Year Published 2024
Journal Ann Dermatol Venereol
MeSH Terms Humans; Hyperbaric Oxygenation; Calciphylaxis; Male; Female; Middle Aged; Retrospective Studies; Aged; Wound Healing; Pain Management; Adult; Chronic Disease; Chronic Pain; Vasculitis; Aged, 80 and over; Treatment Outcome; Leg Ulcer

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology